SMi's Pre-Filled Syringes West Coast conference and exhibition – attendee list released
Following in the steps of the European and Boston events, the San Diego PFS show will once again gather a truly global audience from not only the USA, but also Belgium, Denmark, France, Germany, UK, Japan and more.
ATTENDEE LIST RELEASED – full version is available on the Download Centre of the Pre-Filled Syringes West Coast website. A snap shot of those confirmed attendance:
AbbVie, Allergan, Amgen, Antares Pharma, Aptar Pharma, Baxter Healthcare, Boehringer Ingelheim, Credence MedSystems, Ferring Pharmaceuticals, Genentech, Gilead Science, Glenmark Pharmaceuticals, Ionis Pharmaceuticals, Merck & Co., Novo Nordisk, Pfizer, Regeneron, Shire, Xeris Pharmaceuticals
Spaces are filling up fast – to reserve the seat, book online or contact Fateja Begum - fbegum@smi-online.co.uk / +44 (0)20 7827 6184
As well as providing guidance on regulatory expectations and assessing quality control systems and risk-based control strategies, the agenda for 2018 will also feature a spotlight on human factor engineering, manufacturing in the landscape of complex biologics, and showcase emerging trends of technologies and studies to assist device and drug formulation developers.
To view detailed agenda and find out who is speaking at the event visit http://www.prefilled-syringes-westcoast.com/ein
Incorporated in the PFS West Coast event is an interactive workshop on June 6 - How to leverage tangibles in user testing to ensure successful commercialisation of innovation products – lead by iO Lifesciences
CONTACT:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk
Twitter - @SMIpharm & #smipfsusa
LinkedIn - SMi Pharma
Luda Durneva
SMi Group
email us here
+44 (0)20 7827 6000
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
